Compare ARK Genomic Revolution ETF (ARKG) vs GE Aerospace (GE) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs GE Aerospace — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while GE Aerospace trades at $358.44 (market cap $374.84B). The key difference: GE Aerospace pays a 0.52% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | GE | |
|---|---|---|
Sector | Sector/Thematic | Industrials |
52-Week High | $43.57 | $378.68 |
52-Week Low | $23.09 | $255.42 |
Market Cap | — | $374.84B |
Enterprise Value | — | $384.14B |
Dividend Yield | — | 0.52% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
GE Aerospace trades at $359.27, up 0.06% with a bullish technical signal supported by strong earnings beats and robust order growth. The company demonstrates improving fundamentals with revenue growth from $38.7B to $45.9B (2024-2025) and net income margin expansion to 18.98%. Recent defense contracts and commercial engine demand fuel positive sentiment, though elevated valuation ratios (P/E 44.63, P/S 7.9) warrant caution.
Outlook remains positive with 68.6% analyst buy ratings and $399.43 consensus target offering 11% upside. Key opportunities include aerospace demand surge and defense contract wins, while risks involve high debt levels ($19.27B total debt) and rich valuations that may limit near-term gains despite strong operational performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About GE Aerospace
General Electric Company is a globally diversified technology and financial services company. The Company's products and services include aircraft engines, power generation, water processing, and household appliances to medical imaging, business and consumer financing, and industrial products.
Read more on GE →
